Connecting patients, researchers and clinical genetics services: the experiences of participants in the Australian Ovarian Cancer Study (AOCS)

Ashley Crook; Loren Plunkett; Laura E Forrest; Nina Hallowell; Samantha Wake; Kathryn Alsop; Margaret Gleeson; David Bowtell; Gillian Mitchell; Mary-Anne Young

Journal article

Connecting patients, researchers and clinical genetics services: the experiences of participants in the Australian Ovarian Cancer Study (AOCS)

Ashley Crook, Loren Plunkett, Laura E Forrest, Nina Hallowell, Samantha Wake, Kathryn Alsop, Margaret Gleeson, David Bowtell, Gillian Mitchell, Mary-Anne Young

European Journal of Human Genetics | NATURE PUBLISHING GROUP | Published : 2015

DOI: 10.1038/ejhg.2014.86

University of Melbourne Researchers

Laura Forrest Author The Sir Peter MacCallum Department of Oncology

Gillian Mitchell Author Medicine - St Vincent's Hospital

Kathryn Alsop Author The Sir Peter MacCallum Department of Oncology

David Bowtell Author The Sir Peter MacCallum Department of Oncology

Samantha Wake Author Paediatrics Royal Children's Hospital

Related Projects (2)

Molecular Epidemiology of Ovarian Cancer: The Australian Ovarian Cancer Study National Clinical Follow-Up Core

Ovarian cancer is the seventh most common cancer in Australian women and fifth most common cause of cancer death, with approximately 1200 ne..

AUSTRALIAN OVARIAN CANCER STUDY (AOCS): A MULTIDISCIPLINARY OVARIAN CANCER RESOURCE FOR THE GENOMICS ERA

Ovarian cancer is relatively uncommon and is histologically very diverse, making it difficult to analyse ovarian cancer at a molecular level..

Grants

Awarded by US Army Medical Research and Materiel Command

Awarded by National Health and Medical Research Council of Australia (NHMRC)

Awarded by Ovarian Cancer Research Program of the US Department of Defense

Awarded by Cancer Australia

Funding Acknowledgements

We thank all the women who participated in AOCS, particularly the women and their relatives who took part in the psychosocial study. AOCS was supported by the US Army Medical Research and Materiel Command under DAMD17-01-1-0729, The Cancer Council Victoria, Queensland Cancer Fund, The Cancer Council New South Wales, The Cancer Council South Australia, The Cancer Foundation of Western Australia, The Cancer Council Tasmania and the National Health and Medical Research Council of Australia (NHMRC; ID400413, ID400281). The full study group can be found at www.aocstudy.org. The AOCS prevalence study was supported by the Ovarian Cancer Research Program of the US Department of Defense (W81XWH-08-1-0684 and W81XWH-08-1-0685), Cancer Australia (509303), the Cancer Council Victoria and the Peter MacCallum Cancer Centre Foundation. We gratefully acknowledge the cooperation of the participating institutions in Australia and also the contribution of the study nurses, research assistants and all clinical and scientific collaborators. The complete AOCS study group can be found at www.aocstudy.org.